Related content

Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

By                

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1882-1888

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1272-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2633-2638

Spandidos Publications

Access to resources Recommend Favorite

Intratumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas

By                  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1719-1722

Spandidos Publications

Access to resources Recommend Favorite